一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (431k)
Article in Japanese

Case Report

A case of eosinophilic granulomatosis with polyangiitis diagnosed during the treatment of ulcerative colitis

Akane Naritaa  Munetake Takadaa  Yutaka Matsuzakib  Hitomi Fujimotob  Kouji Azuhatac  Masanori Nakanishia 

aDepartment of Respiratory Medicine, Aizawa Hospital
bDepartment of Gastroenterology, Aizawa Hospital
cDepartment of Pathology, Aizawa Hospital

ABSTRACT

The case is a 51-year-old man whose bronchial asthma and allergic rhinitis had been treated for more than ten years and whose ulcerative colitis (UC) had been treated with mesalazine for one year. His UC deteriorated and his symptoms were improved by the administration of prednisolone (PSL) and azathioprine (AZP). After the cessation of PSL and AZP, he presented with wheezing, fever, eosinophilia, sinusitis, and multiple infiltrates on his chest computed tomography. Histopathological findings from the transbronchial lung biopsy specimens showed a large number of eosinophils in the alveolar spaces. The collections of macrophages included multinucleated giant cells indicating the presence of granulomas, and occlusion of the vascular lumen and rupture of the elastic fiber in the peripheral pulmonary artery demonstrated vasculitis. He was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA). PSL 40 mg was administered and resulted in prompt improvement, and his symptoms and the infiltrates on computed tomography disappeared in one month. After that PSL was tapered to 10 mg and, up until the time of writing, there has been no deterioration in EGPA or UC symptoms. Although reports of EGPA associated with UC are rare, it is important to be alert for complications while these diseases are treated.

KEYWORDS

Eosinophilic granulomatosis with polyangiitis (EGPA)  Antineutrophil cytoplasmic antibody (ANCA)  ANCA-associated vasculitis (AAV)  Ulcerative colitis (UC)  Inflammatory bowel disease (IBD) 

Received 31 Oct 2022 / Accepted 23 Mar 2023

AJRS, 12(4): 225-229, 2023

Google Scholar